Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary

BACKGROUND: For cancer of unknown primary (CUP), non-selective empiric chemotherapy is usually used. However, patients suffering from CUP are generally assumed to have a dismal prognosis with median overall survival of less than 1 year. Therefore, clinicians eagerly await the establishment of effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bo, Wang, Qifeng, Liu, Xin, Hu, Silong, Zhou, Liangping, Xu, Qinghua, Sun, Yifeng, Hu, Xichun, Luo, Zhiguo, Zhang, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005951/
https://www.ncbi.nlm.nih.gov/pubmed/35433426
http://dx.doi.org/10.3389/fonc.2022.723140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005951/
https://www.ncbi.nlm.nih.gov/pubmed/35433426
http://dx.doi.org/10.3389/fonc.2022.723140

Ejemplares similares